Interferon γ-induced gene expression of the novel secretory phospholipase A2 type IID in human monocyte-derived macrophages is inhibited by lipopolysaccharide

Inflammation

Volumn 29, Issue 2-3, 2005, Pages 44-53

  Lindbom, John ^a   Ljungman, Anders G ^a   Tagesson, Christer ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

IFN ; LPS; Macrophages; Nasal mucosa; PLA2

Indexed keywords

GAMMA INTERFERON; I KAPPA B; LIPOPOLYSACCHARIDE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 TYPE IIA; PHOSPHOLIPASE A2 TYPE IID; PHOSPHOLIPASE A2 TYPE IVA; PYRROLIDINE DITHIOCARBAMATE; UNCLASSIFIED DRUG; WORTMANNIN;

ARTICLE; CELL STIMULATION; CELL TYPE; CONTROLLED STUDY; GENE EXPRESSION; HOUSEKEEPING GENE; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 33646132893     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10753-006-9007-x     Document Type: Article

References (62)

1. Barnes P. J., K. F. Chung, C. P. Page. 1998. Inflammatory mediators of asthma: an update. Pharmacol. Rev.50:515-596.
2. 2: isolation of the human gene and cDNAs from porcine pancreas and human lung. DNA 6:519-527.
3. 2 present in rheumatoid arthritic synovial fluid. J. Biol. Chem. 264:5335-5338.
4. 2s. J. Biol. Chem. 274:24973-24979.
5. 2. J. Biol. Chem. 275:5785-5793.
6. 2. Biochem. Biophys. Res. Commun. 279:223-228.
7. 2 with homology to the group III bee venom enzyme. J. Biol. Chem. 275:7492-7496.
8. 2+-dependent translocation domain with homology to PKC and GAP. Cell 65:1043-4051.
9. 2. J. Biol. Chem. 274:8823-8831.
10. 2. J. Biol. Chem. 273:21926-21932.
11. 2. J. Biol. Chem. 269:2365-2368.
12. 2 and their effect on enzyme activity. J. Biol. Chem. 273:207-214.
13. 2. J. Biol. Chem. 275:9937-9945.
14. 2. Biochem. Biophys. Res. Commun. 272:320-326.
15. Tjoelker L., C. Wilder, C. Eberhardt, D. Stafforini, G. Dietsch, B. Schimpf, S. Hooper, H. Trong, L. Cousens, G. Zimmerman, Y. Yamada, T. McIntyre, S. Prescott, P. Gray. 1995. Antiinflammatory properties of a platelet-activating factor acetylhydrolase. Nature 374:549-553.
16. Tew D., C. Southan, S. Rice, M. Lawrence, H. Li, H. Boyd, K. Moores, I. Gloger, C. Macphee. 1996. Purification, properties, sequencing, and cloning of a lipoprotein-associated, serine-dependent phospholipase involved in the oxidative modification of low-density lipoproteins. Arterioscler. Thromb. Vasc. Biol. 16:591-599.
17. Hattori K., H. Adachi, A. Matsuzawa, K. Yamomoto, M. Tsujimoto, J. Aoki, M. Hattori, H. Arai, K. Inoue. 1996. cDNA cloning and expression of intracellular platelet-activating factor (PAF) acetylhydrolase II. J. Biol. Chem. 271:33032-33038.
18. Adachi H., M. Tsjuimoto, M. Hattori, H. Arai, K. Inoue. 1995. cDNA cloning of human cytosolic platelet-activating factor acetylhydrolase γ-subunit and its mRNA expression in human tissues. Biochem. Biophys. Res. Com. 214:180-187.
19. Adachi H., M. Tsujimoto, M. Hattori, H. Arai, K. Inoue. 1997. Differential tissue distribution of the β- and γ-subunits of human cytosolic platelet-activating factor acetylhydrolase (isoform I). Biochem. Biophys. Res. Com. 233:10-13.
20. 2. J. Biol. Chem. 272:15745-15752.
21. 2. J. Biol. Chem. 275:39823-39826.
22. 2 lacking enzymatic activity. Biochemistry 42:11494-11503.
23. 2 superfamily of signal transduction enzymes. Trends Biochem. Sci. 22:1-2.
24. 2. Annu. Rev. Pharmacol. Toxicol. 39:175-189.
25. 2 blocks arachidonic acid release from airway epithelial cells. Am. J. Physiol. 273:L331-L338.
26. 2. J. Clin. Invest. 93:571-577.
27. 2: its usefulness in laboratory diagnostics. Crit. Rev. Clin. Lab. Sci. 36:65-163.
28. 2 in human arterial smooth muscle cells. Involvement of cell differentiation, STAT-3 activation, and modulation by other cytokines. J. Biol. Chem. 275:22895-22904.
29. 2 types in human airway epithelial cells induced by tumor necrosis factor-α and IFN-γ. J. Interferon. Cytokine. Res. 22:947-955.
30. Van Cauwenberge P. B. 1997. Nasal sensitization. Allergy 52:7-9.
31. 2 family of enzymes in human nasal mucosa. Eur. Respir. J. 18:130-138.
32. Gantner F., R. Kupferschmidt, C. Schudt, A. Wendel, A. Hatzelmann. 1997. In vitro differentiation of human monocytes to macrophages: change of PDE profile and its relationship to suppression of tumour necrosis factor-alpha release by PDE inhibitors. Br. J. Pharmacol. 121:221-231.
33. Hammerstrom J. 1979. Human macrophage differentiation in vivo and in vitro. A comparison of human peritoneal macrophages and monocytes. Acta Pathol. Microbiol. Scand. C. 87: 113-120.
34. Nii A., S. Sone, E. Orino, T. Ogura. 1993. Induction of a 26-kDa membrane-form tumor necrosis factor (TNF)-alpha in human alveolar macrophages. J. Leukoc. Biol. 53:29-36.
35. Murakami M., K. Yoshihara, S. Shimbara, M. Sawada, N. Inagaki, H. Nagai, M. Naito, T. Tsuruo, T. C. Moon, H. W. Chang, I. Kudo. 2002. Group IID heparin-binding secretory phospholipase A(2) is expressed in human colon carcinoma cells and human mast cells and up-regulated in mouse inflammatory tissues. Eur. J. Biochem. 269:2698-2707.
36. Siebenlist U., G. Franzoso, K. Brown. 1994. Structure, regulation and function of NF-kappa B. Annu. Rev. Cell Biol. 10:405-455.
37. Kumar A., J. Haque, J. Lacoste, J. Hiscott, B. R. Williams. 1994. Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B. Proc. Natl. Acad. Sci. U.S.A. 91:6288-6292.
38. Velasco M., M. J. Diaz-Guerra, P. Martin-Sanz, A. Alvarez, L. Bosca. 1997. Rapid up-regulation of IkappaBbeta and abrogation of NF-kappaB activity in peritoneal macrophages stimulated with lipopolysaccharide. J. Biol. Chem. 272:23025-23030.
39. Yamazaki S., T. Muta, K. Takeshige. 2001. A novel IkappaB protein, IkappaB-zeta, induced by proinflammatory stimuli, negatively regulates nuclear factor-kappaB in the nuclei. J. Biol. Chem. 276:27657-27662.
40. Muta T., S. Yamazaki, A. Eto, M. Motoyama, K. Takeshige. 2003. IkappaB-zeta, a new anti-inflammatory nuclear protein induced by lipopolysaccharide, is a negative regulator for nuclear factor-kappaB. J. Endotoxin. Res. 9:187-191.
41. Murakami M., K. Yoshihara, S. Shimbara, M. Sawada, N. Inagaki, H. Nagai, M. Naito, T. Tsuruo, T. C. Moon, H. W. Chang, I. Kudo. 2002. Group IID heparin-binding secretory phospholipase A(2) is expressed in human colon carcinoma cells and human mast cells and up-regulated in mouse inflammatory tissues. Eur. J. Biochem. 269:2698-2707.
42. 2s in human embryonic kidney 293 and rat mastocytoma RBL-2H3 cells through heparan sulfate shuttling and external plasma membrane mechanisms. J. Biol. Chem. 276:10083-10096.
43. 2 causes surfactant dysfunction. Chest 123:376S-377S.
44. Koduri R. S., J. O. Gronroos, V. J. Laine, C. Le Calvez, G. Lambeau, T. J. Nevalainen, M. H. Gelb. 2002. Bactericidal properties of human and murine groups I, II, V, X, and XII secreted phospholipases A(2). J. Biol. Chem. 277:5849-5857.
45. Schreck R., B. Meier, D. N. Mannel, W. Droge, P. A. Baeuerle. 1992. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J. Exp. Med. 175:1181-1194.
46. Schreck R., R. Grassmann, B. Fleckenstein, P. A. Baeuerle. 1992. Antioxidants selectively suppress activation of NF-kappa B by human T-cell leukemia virus type I Tax protein. J. Virol. 66:6288-6293.
47. Guha M., N. Mackman. 2002. The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J. Biol. Chem. 277:32124-32132.
48. Rosenberger C. M., B. B. Finlay. 2003. Phagocyte sabotage: disruption of macrophage signaling by bacterial pathogens. Nat. Rev., Mol. Cell Biol. 4:385-396.
49. 2 gene. Nucleic Acids Res. 22:5093-5098.
50. 2 gene. Biochem. Biophys. Res. Commun. 205:6-11.
51. 2 gene expression in cultured human bronchial epithelial cells. Biochim. Biophys. Acta 1355:121-130.
52. Dolan-O'Keefe M., V. Chow, J. Monnier, G. A. Visner, H. S. Nick. 2000. Transcriptional regulation and structural organization of the human cytosolic phospholipase A(2) gene. Am. J. Physiol. Lung Cell Mol. Physiol. 278:L649-L657.
53. 2 in lung epithelial cells and non-small cell lung cancer is mediated by Sp1 and c-Jun. J. Biol. Chem. 276:42737-42743.
54. Gutcher I., P. R. Webb, N. G. Anderson. 2003. The isoform-specific regulation of apoptosis by protein kinase C. Cell Mol. Life Sci. 60:1061-1070.
55. Matte C., G. Maion, W. Maurad, M. Olivier. 2001. Leishmania donovani-induced macrophages cyclooxygenase-2 and prostaglandin E2 synthesis. Parasite Immunol. 23:177-184.
56. Rao K. M. 2001. MAP kinase activation in macrophages. J. Leukoc. Biol. 69:3-10.
57. Wright S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431-1433.
58. Hoshino K., O. Takeuchi, T. Kawai, H. Sanjo, T. Ogawa, Y. Takeda, K. Takeda, S. Akira. 1999. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the LPS gene product. J. Immunol. 162:3749-3752.
59. Andreani M., J. L. Olivier, F. Berenbaum, M. Raymondjean, G. Bereziat. 2000. Transcriptional regulation of inflammatory secreted phospholipases A(2). Biochim. Biophys. Acta 1488:149-158.
60. Roy S. K., S. J. Wachira, X. Weihua, J. Hu, D. V. Kalvakolanu. 2000. CCAAT/enhancer-binding protein-beta regulates interferon-induced transcription through a novel element. J. Biol. Chem. 275:12626-12632.
61. Salmenpera P., S. Hamalainen, M. Hukkanen, E. Kankuri. 2003. Interferon-gamma induces C/EBP beta expression and activity through MEK/ERK and p38 in T84 colon epithelial cells. Am. J. Physiol. Cell Physiol. 284:C1133-C1139.
62. Gillies S. D., S. L. Morrison, V. T. Oi, S. Tonegawa. 1983. A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene. Cell 33:717-728.